Office of Research and Technology Management
Identify Funding Proposals Proposal Development Award Management Compliance Review and Oversight Education and Training Technology Transfer
Research Newsletter
CWRU ORA - News and Funding Opportunities
January 5, 2018  

Funding Opportunities

Michelson Medical Research Foundation
The Michelson Medical Research Foundation (MMRF) together with the Human Vaccines Project have established the Michelson Prizes for Human Immunology and Vaccine Research. The $20 million initiative, funded by the MMRF and administered by the Human Vaccines Project, aims to support young investigators applying innovative research concepts and disruptive technologies to significantly advance the development of future vaccines and therapies to defeat major global diseases. While the Michelson Prizes are focused on research outcomes in the fields of human immunology and vaccinology, applicants from the full spectrum of related disciplines, including clinical research, biomedicine, artificial intelligence/machine learning, engineering, and nanotechnology are encouraged to apply. Proposals will be reviewed and winners selected by a distinguished committee of internationally-recognized research scientists.

Experience in human immunology or vaccine research is not required; however, the application must focus on human immunology or vaccine research, and the applicant must maintain a 50% dedication of his/her full-time professional effort during the award period to the research funded by this award.

Individuals from other disciplines who will apply novel concepts to human immunology and vaccine research are also encouraged to apply.

The applicant is expected to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals proposed in the application.

The applicant must be under the age of 35 at the time of pre-application submission (February 12, 2018). Early career independent investigators, postdoctoral fellows, clinical fellows (including residents and interns), and other researchers currently in training positions are eligible for this award. An eligible applicant, regardless of ethnicity, nationality or citizenship status, must be employed by or affiliated with, an eligible organization. Examples of eligible organizations include academia, biotechnology companies, foundations, government and non-governmental organizations, and research institutes. Individuals from such organizations, including organizations based outside of the US, are eligible to apply. Each applicant may submit only one Michelson Prize application per year. Note: The Michelson Prizes for Human Immunology and Vaccine Research will be awarded to individuals, not institutions.

Pre-application Deadline: February 12, 2018
Invited Application Deadline: April 02, 2018

For more information visit the MMRF website.

NIH - End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional)
This funding opportunity announcement (FOA) seeks to stimulate research focused on identification of the key barriers to effective end-of-life and palliative care (EOLPC) health literacy in diverse settings and populations, and to create novel strategies, interventions, and models of care to improve EOLPC health literacy, with the goal of improving outcomes for individuals with serious, advanced illness and their families and caregivers.

Application Deadline: February 5, 2018

For more information visit the NIH website.

NIH Center for Accelerated Innovations at Cleveland Clinic
The NIH Center for Accelerated Innovation a Cleveland Clinic (NCAI-CC) has announced the Request for Applications (RFA) for a special targeted funding opportunity for Cleveland Clinic, Case Western Reserve University, The Ohio State University, Cincinnati Children’s Hospital,

The goal of this special funding opportunity is to identify, select, and advance qualified projects in special areas of clinical interest identified by the National Heart, Lung and Blood Institute (NHLBI), including:
  • Chronic Obstructive Pulmonary Disease
  • Idiopathic Pulmonary Fibrosis
  • Pulmonary Hypertension
  • Heart Failure
  • Myocardial Infarction
  • Non-statin Lipid Lowering Drugs
  • Sickle Cell Anemia
This funding opportunity is open to diagnostic assays, tests or systems; interventional, surgical, or therapeutic devices; therapeutic pharmaceutical, biologic, or regenerative medicine product solutions.

Funding Available. Total funding amount up to $150,000 will be available per project. Up to $75,000 to be provided by federal grant administered by NCAI, plus matching funds in an equivalent amount to be secured and provided through the project institution.

Pre-Qualification. Candidate projects must be discussed with and pre-approved by NCAI-CC product development directors and home institution technology commercialization office representatives prior to submission.

Application Deadline: January 24, 2018

For more informaiton, visit the NCAI-CC webpage
Established by Nikon, Inc. as part of its hundredth anniversary celebration, the Nikon Storytellers Scholarship supports the next generation of visual content creators. Academic scholarships of $10,000 will be awarded to students to help foster their creative growth and encourage them to pursue a career in creative fields. Semi-finalists will be invited to submit a portfolio of images or brief video for consideration by a selection committee, which will then select the ten winning applicants. Scholarships will be awarded for use in the 2018-19 academic school year.

The program is open to undergraduate and graduate students at accredited nonprofit colleges/universities or vocational/technical schools in the United States or Canada pursuing a degree in visual arts, fine arts, journalism, film, photography, or multimedia/content creation. To be eligible for a scholarship, all applicants must have completed their freshman year of college or academic equivalent before the fall of 2018.

Application Deadline: March 1, 2018

For more information visit the Nikon website.

Transportation Research Board
Run-off-road (ROR) traffic crashes account for almost one-third of the deaths and serious injuries each year on U.S. highways. The effective design of roadsides, including the placement of roadside safety devices, can reduce the frequency and/or severity of these crashes but requires an understanding of the nature and frequency of roadside encroachments. Unfortunately, the best quality encroachment data currently available were collected in the 1960s and 1970s. The age of these datasets means they are likely no longer representative of the current vehicle fleet or highway conditions. Further, each of these datasets has significant limitations, including specific exclusion of heavy vehicles and motorcycles and a very limited range of traffic volumes (i.e., less than 20,000 vehicles per day); such limitations have fostered much debate over the value of findings from these studies.

Immense progress has taken place in both the development of new roadside safety devices and in the improvement of existing devices since the 1960s. Proper development, testing, and placement of these devices along the roadside, however, is required to maximize their effectiveness. The guidelines for development, testing, and placement of these devices rely heavily on roadside encroachment data across the range of traffic volumes and vehicle types.

There is a critical need to collect new roadside encroachment data to understand the frequency and nature of encroachments across the entire vehicle fleet. These data will guide refinement of current crash testing procedures in the Manual for Assessing Safety Hardware (MASH) and facilitate updates to the Roadside Design Guide (RDG) and potentially the Highway Safety Manual (HSM). Thus, this research is supported by the Technical Committee on Roadside Safety’s (TCRS) Strategic Plan.

The objectives of this research are to

(1) develop a database of roadside encroachment characteristics for a variety of roadside conditions and roadway types and

(2) analyze the database to evaluate

  • the effects of the characteristics on the nature and frequency of roadside encroachments,
  • the relationship between unreported and reported crashes, and
  • whether heavy vehicles, buses, and motorcycles encroach differently than passenger vehicles
Development of the database should address the following roadside encroachment characteristics, at a minimum:

  • Pre-encroachment conditions;
  • Cross-sectional elements;
  • Rural v. urban;
  • Urban curbed v. uncurbed;
  • Vehicle type;
  • Various traffic volumes and speeds;
  • Horizontal and vertical alignments;
  • Levels-of-service; and
  • Number of lanes, lane width, and access density
Further, the database development should address the following roadside encroachment outcomes, at a minimum: reported and unreported; intentional and unintentional; tracking v. non-tracking; runoff distance; vehicle trajectory; and crash severity.

Application Deadline: January 30, 2018.

For more information visit the TRB website.

Take Advantage of All Pivot Has to Offer

For years, Community of Science (COS) has been recognized around the world for its funding from a wide variety of sources as well as its access to the world’s research community.

CWRU has subscribed to COS's new product, Pivot, which provides you the edge by bringing together the right research opportunities, funding, and people—quickly and easily. It provides global and local connections that strengthen research by exploring new avenues for funding and collaboration—for faculty, staff researchers, and graduate students.

Pivot can:

  • provide access to the most comprehensive global source of funding opportunities;
  • identify research expertise from within or outside of CWRU;
  • foster collaboration by cultivating essential partnerships and alliances; and
  • build strong network connections for future opportunities.
Learn more about how to use all the features Pivot has to offer.

Learn to use Pivot via YouTube:


Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not be moved or deleted.